![Kim Warren](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kim Warren
Chief Operating Officer at Horizon Education LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael May | M | 56 |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Christopher Paige | M | 71 |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | 8 years |
Peter Zandstra | M | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Jesse Cotari | M | - |
ImmuneBridge, Inc.
![]() ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | 6 years |
Dustin Bainbridge | M | - |
Horizon Education LLC
![]() Horizon Education LLC Miscellaneous Commercial ServicesCommercial Services Horizon Education LLC offers postsecondary readiness programs to help high school students prepare for graduation and college entrance exams. The company is based in Laguna Beach, CA. The company was founded in 2013 by Dustin Bainbridge and Michelle Sauceda. Dustin Bainbridge has been the CEO since 2013. Horizon Education was acquired by Progress Learning LLC on June 23, 2022. | 11 years |
Peretz Partensky | M | - |
ImmuneBridge, Inc.
![]() ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | 6 years |
Reni J. Benjamin | M | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Leah Cowen | F | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Sofia Hjelmberg | F | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | 1 years |
Dylan Morris | M | - |
ImmuneBridge, Inc.
![]() ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | 1 years |
Alicia Marie Jackson | M | - |
ImmuneBridge, Inc.
![]() ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | - |
Karin Flyborg | F | 63 |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Philip Vanek | M | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | 9 years |
Donna Wall | M | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Michael Nobrega | M | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Sven Kili | M | 57 |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | 7 years |
Allen L. Burgenson | M | - |
Lonza Walkersville, Inc.
![]() Lonza Walkersville, Inc. Pharmaceuticals: MajorHealth Technology Lonza Walkersville, Inc. develops, manufactures and provides testing services for cell-based therapeutics. Its services include life-science customers, research organizations, pharmaceutical, biopharmaceutical, biotechnology and generic drug companies. The company was founded was founded on May 9, 1991 and is headquartered in Walkersville, MD. | - |
David W. Smith | M | - |
Lonza Walkersville, Inc.
![]() Lonza Walkersville, Inc. Pharmaceuticals: MajorHealth Technology Lonza Walkersville, Inc. develops, manufactures and provides testing services for cell-based therapeutics. Its services include life-science customers, research organizations, pharmaceutical, biopharmaceutical, biotechnology and generic drug companies. The company was founded was founded on May 9, 1991 and is headquartered in Walkersville, MD. | - |
Claudia Zylberberg | M | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Joan Sheehan | F | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Gregory Bonfiglio | M | 72 |
ImmuneBridge, Inc.
![]() ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | - |
Jana Machan | F | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Erik Ostrowski | M | 51 | 5 years | |
Geoff MacKay | M | 57 | 8 years | |
Philip Donenberg | M | 63 | - | |
Joshua Resnick | M | 49 | 2 years | |
Azadeh Golipour | M | - | 8 years | |
Christopher Mason | M | 66 | 7 years | |
Steven Avruch | M | 63 | 5 years | |
Ian Clark | M | 62 | 6 years | |
Katina Dorton | F | 66 | 1 years | |
Jonathan Yeh | M | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | 3 years |
Annalisa Jenkins | M | 58 | 6 years | |
Philip Vickers | M | 64 | 5 years | |
Scott Requadt | M | 56 | 2 years | |
Bruce Booth | M | 49 | 8 years | |
Georgette Verdin | F | - | - | |
Kirsten Dupuis | F | - | - | |
Christopher Gerry | M | - | 3 years | |
Matt Arnold | M | - | - | |
Kim Raineri | M | - | 2 years | |
Josie Yang | M | - | - | |
Vivek Goel | M | - |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | - |
Birgitte Volck | M | 61 | 2 years | |
Holly May | F | - | - | |
Jeffrey Medin | M | - | - | |
Gabriel Cohn | M | 65 | 2 years | |
Deanna M. Petersen | F | 62 | 7 years | |
Monique da Silva | F | - | - | |
Nerissa Kreher | M | 51 | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 35 | 70.00% |
Canada | 16 | 32.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kim Warren
- Personal Network